Glucagon-like peptide 1 receptor agonists and the clinical outcomes of inflammatory bowel disease: a systematic review and meta-analysis
A dietitian can help adjust food choices, portion sizes, and meal timing to improve comfort, support better tolerance to GLP-1 treatment, and maintain good nutrition while using GLP-1 medicines 8
Cases involving gastrointestinal harms will remain with MDL 3094
For most weight management patients, GLP-1 is out-of-pocketeither through us or through their insurance with prior authorization
Common Side Effects and Safety Considerations Gastrointestinal side effects are the most frequently reported adverse reactions with GLP-1 receptor agonists, affecting a substantial proportion of patients, particularly during treatment initiation
Irregular meal patterns or inadequate carbohydrate intake Skipping meals, fasting, or consuming insufficient carbohydrates while on glucose-lowering therapy increases hypoglycaemia risk